ESR1 c.352_353inv ;(p.S118E)

Variant ID: 6-152129399-TC-GA

NM_000125.3(ESR1):c.352_353inv;(p.S118E)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability.

Cells
Jeffreys, Sarah A SA; Powter, Branka B; Balakrishnar, Bavanthi B; Mok, Kelly K; Soon, Patsy P; Franken, André A; Neubauer, Hans H; de Souza, Paul P; Becker, Therese M TM
Publication Date: 2020-09-11

Variant appearance in text: ESR1: S118E
PubMed Link: 32932819
Variant Present in the following documents:
  • Main text
  • cells-09-02077.pdf
View BVdb publication page



Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer.

The Journal Of Steroid Biochemistry And Molecular Biology
Bratton, Melyssa R MR; Martin, Elizabeth C EC; Elliott, Steven S; Rhodes, Lyndsay V LV; Collins-Burow, Bridgette M BM; McLachlan, John A JA; Wiese, Thomas E TE; Boue, Stephen M SM; Burow, Matthew E ME
Publication Date: 2015-06

Variant appearance in text: ER-alpha: S118E
PubMed Link: 25771071
Variant Present in the following documents:
  • Main text
View BVdb publication page



Formation of an hER alpha-COUP-TFI complex enhances hER alpha AF-1 through Ser118 phosphorylation by MAPK.

The Embo Journal
Métivier, Raphaël R; Gay, Frédérique A FA; Hübner, Michael R MR; Flouriot, Gilles G; Salbert, Gilles G; Gannon, Frank F; Kah, Olivier O; Pakdel, Farzad F
Publication Date: 2002-07-01

Variant appearance in text: NR3A1: S118E
PubMed Link: 12093745
Variant Present in the following documents:
  • Main text
View BVdb publication page